Navigation Links
Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C
Date:4/25/2009

scussions with regulatory authorities - and we believe that Albuferon, assuming licensure, could become a leading treatment for chronic hepatitis C."

The Phase 3 studies, known as ACHIEVE 1 and ACHIEVE 2/3, evaluated albinterferon alfa-2b vs. peginterferon alfa-2a, in combination with ribavirin, for use in the treatment of interferon-naive patients with chronic hepatitis C. ACHIEVE 1 was conducted in patients infected with genotype 1 virus, and ACHIEVE 2/3 was conducted in patients with genotypes 2 and 3 virus. The two studies treated a combined total of 2255 treatment-naive patients.

"The results of two Phase 3 trials demonstrate that 900-mcg albinterferon alfa-2b administered every two weeks provides efficacy comparable to peginterferon alfa-2a administered weekly, with a positive safety profile," said David Nelson, M.D., Professor of Medicine, Medical Director of Liver Transplantation, and Chief of the Hepatobiliary Disease Section, University of Florida. Dr. Nelson presented the results from ACHIEVE 2/3.

Stefan Zeuzem, M.D., Professor of Medicine and Chief, Department of Medicine, J.W. Goethe University Hospital, Frankfurt, Germany, presented the ACHIEVE 1 results, and said, "The data presented at EASL suggest that albinterferon alfa-2b has the potential to become an important and novel treatment option for patients with chronic hepatitis C."

Phase 3 Efficacy Findings

Based on an intention-to-treat (ITT) analysis, the data presented at EASL demonstrate that albinterferon alfa-2b met its primary efficacy endpoint of non-inferiority to peginterferon alfa-2a in both ACHIEVE 1 and ACHIEVE 2/3:

  • ACHIEVE 1: 48.2% (213/442) of patients in the 900-mcg albinterferon alfa-2b treatment group achieved sustained virologic response (SVR), vs. 51.0% (225/441) in the peginterferon alfa-2a treatment group. The primary analy
    '/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrines Fully Human Anti-PS Antibody in Prostate Cancer Model
2. Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells
3. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
4. First Human Study to Show Sun Chlorella A Supports Heart Health
5. Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
6. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
7. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
8. Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
9. Drug Development Program Started Based on CAP(R) Human Cell Line
10. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
11. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- Fibich, Leebron, Copeland, Briggs & Josephson is pleased ... reached to resolve lawsuits involving individuals who were allegedly ... manufactured by Takeda Pharmaceuticals - has been associated with ... the firm,s attorneys were instrumental in the coordination and ... - Founding Partner of Fibich, Leebron, Copeland, Briggs ...
(Date:5/6/2015)... and PRETORIA, South Africa , May ... cancer kills more people than HIV/AIDS, malaria and tuberculosis combined[1]. ... 40 percent can be cured with the right treatment[3]. Together ... nations are working to build up their radiation therapy infrastructures ... all cancer patients worldwide would benefit from radiation therapy[4] during ...
(Date:5/6/2015)... 2015 Research and Markets ( ... "Chromatography (Instruments and Reagents) Global Market - ... Chromatography is an analytical technique, a ... a complex mixture by differential movement through a ... have considered chromatography as an esoteric art, which ...
Breaking Medicine Technology:Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2
... May 3, 2011 Solta Medical, Inc. (NASDAQ: ... today announced results for the first quarter ended March 31, ... 2% increase as compared to the first quarter of 2010. ... 18% as compared to the first quarter of 2010, and ...
... May 3, 2011 Idenix Pharmaceuticals, Inc. (NASDAQ: ... corporate overview at the Bank of America Merrill Lynch 2011 ... PT at the Wynn Encore, Las Vegas. ... be accessed under "Calendar of Events" in the Idenix Investor ...
Cached Medicine Technology:Solta Medical Reports First Quarter Results 2Solta Medical Reports First Quarter Results 3Solta Medical Reports First Quarter Results 4Solta Medical Reports First Quarter Results 5Solta Medical Reports First Quarter Results 6Solta Medical Reports First Quarter Results 7
(Date:5/6/2015)... MJNational LLC strengthens its consultant agreement to ... ™ platform. This exciting new SMS platform creates quite ... / Services. Now you can reach out to ... services and ticker symbol through an easy to use ... will provide managed support and services to advance the ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 On April ... on Plastic Surgery ,” compiled quotes about cosmetic ... Jennifer Aniston, pop singer Iggy Azalea, and Gwyneth Paltrow. ... sentiments about having plastic surgery themselves; only ... society and its expectations of youth and beauty. (see: ...
(Date:5/6/2015)... 06, 2015 Corporate Executives Mark ... MEBC, an Alliance Award for excellence in consulting ... 2015, JDA’s annual user conference which brought together ... wholesale distribution sectors. This award recognizes MEBC, Inc. ... services that advance their supply chain performance and ...
(Date:5/6/2015)... 2015 Baptist Medical Center Jacksonville ... in north Florida and southeast Georgia region offering ... innovation in total hip replacement surgery performed using ... arm that enables the accurate alignment and positioning ... offered MAKOplasty® partial knee resurfacing using the RIO ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as part ... and coolest applications on the market for iOS, Android, and Windows. ... app review and shared with viewers how this application walks users ... be a good navigator people had to know how to read ... a master navigator. Well what if people could “GPS” their way ...
Breaking Medicine News(10 mins):Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 2Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 3Health News:Plastic Surgery: Sixteen Celebrities Offer their Opinion about Going Under the Knife 2Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2
... and China's first facial transplant patient would have to wait ... surgery has been a success. He is showing signs of ... ,Li Guoxing, bear attack victim underwent a partial ... a hospital in north-western China on the 14th of April. ...
... people with chest pain (non cardiac) may find ... sense of general well-being.//, ,The researchers are ... Hospital in Manchester who have previously shown that ... respond well to hypnotherapy., ,Based on those ...
... Concerns of citizens over the poisonous vegetables found in ... voluntary registration system// for local farms. Additionally, supermarket chains ... a comprehensive tracking system for farm produce, according to ... system has been pointed out by a Hong Kong's ...
... Secretary, Pramod Mahajan is currently critical after being shot by ... his residence.// Pramod is currently being ventilated in the Intensive ... critical. , ,Mr.Mahajan, a known diabetic received four bullets ... fired at close range and went through the liver, shattering ...
... a senior nurse so that the elderly are treated with ... the government. // Ministers said there would be an attitude ... in the hospitals. <br,Professor Ian Philp, the government's older ... to rigorous checks in order to ensure that they comply ...
... turn when the Texas jury awarded $32 million for the family ... Vioxx. // But this will be greatly reduced by state law. ... against Vioxx maker Merck & Co. Inc. , ... for mental anguish and personal loss and $25 million in punitive ...
Cached Medicine News:Health News:Review of Pramod Mahajan's Injuries 2Health News:Merck in the Dock Due To Vioxx 2
... deep vein thrombosis, the Aircast VenaFlow System ... compression and rapid impulse inflation. This combination ... ejection while producing more shear stress to ... with tube assembly (cuffs are sold separately). ...
... Transportability: Innovative design allows the clinician ... for therapy or when to take ... the prophylactic method to deliver compression ... simultaneously. ,Automatic Garment Detection: Automatically detects ...
... new cast boot specially lasted for ... double rocker sole for easy ambulation! ... a narrow last so it fits ... boots, and with our stretchable upper, ...
The Low Profile boot provides a durable canvas upper, with an open toe and heel. Padded EVA insole protection. The lower outsole compensates for casting thickness. Available in six unisex sizes....
Medicine Products: